Amgen Inc.
REDUCED VISCOSITY PROTEIN PHARMACEUTICAL FORMULATIONS
Last updated:
Abstract:
Described herein are therapeutic protein formulations comprising N-methyl pyrrolidone (NMP), methods related to reducing viscosity of pharmaceutical formulations and methods related to stabilizing pharmaceutical formulations using NMP.
Status:
Application
Type:
Utility
Filling date:
6 Oct 2017
Issue date:
23 Jan 2020